These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 10328304)

  • 21. Biochemical and pharmacologic rationale for the development of a synthetic heparin pentasaccharide.
    Walenga JM; Jeske WP; Bara L; Samama MM; Fareed J
    Thromb Res; 1997 Apr; 86(1):1-36. PubMed ID: 9172284
    [No Abstract]   [Full Text] [Related]  

  • 22. Inhibitory effects of TFPI on thrombin and factor Xa generation in vitro--modulatory action of glycosaminoglycans.
    Kaiser B; Hoppensteadt DA; Jeske W; Wun TC; Fareed J
    Thromb Res; 1994 Sep; 75(6):609-16. PubMed ID: 7831680
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthetic heparin derivatives as new anticoagulant drugs.
    de Kort M; Buijsman RC; van Boeckel CA
    Drug Discov Today; 2005 Jun; 10(11):769-79. PubMed ID: 15922935
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Calcium enhances heparin catalysis of the antithrombin-factor Xa reaction by promoting the assembly of an intermediate heparin-antithrombin-factor Xa bridging complex. Demonstration by rapid kinetics studies.
    Rezaie AR; Olson ST
    Biochemistry; 2000 Oct; 39(39):12083-90. PubMed ID: 11009624
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heparinase I acts on a synthetic heparin pentasaccharide corresponding to the antithrombin III binding site.
    Yu G; LeBrun L; Gunay NS; Hoppensteadt D; Walenga JM; Fareed J; Linhardt RJ
    Thromb Res; 2000 Dec; 100(6):549-56. PubMed ID: 11152935
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Orgaran (Org 10172): its pharmacological profile in experimental models.
    Meuleman DG
    Haemostasis; 1992; 22(2):58-65. PubMed ID: 1379965
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A new synthetic pentasaccharide with increased anti-factor Xa activity: possible role for anionic clusters in the interaction of heparin and antithrombin III.
    Petitou M; Lormeau JC; Choay J
    Semin Thromb Hemost; 1991; 17 Suppl 2():143-6. PubMed ID: 1948084
    [No Abstract]   [Full Text] [Related]  

  • 28. New anticoagulants: anti IIa vs anti Xa--is one better?
    Bauer KA
    J Thromb Thrombolysis; 2006 Feb; 21(1):67-72. PubMed ID: 16475045
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A synthetic antithrombin III binding pentasaccharide is now a drug! What comes next?
    Petitou M; van Boeckel CA
    Angew Chem Int Ed Engl; 2004 Jun; 43(24):3118-33. PubMed ID: 15199558
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of oversulphated chondroitin and dermatan sulphate upon thrombin and factor Xa inactivation by antithrombin III or heparin cofactor II.
    Scully MF; Ellis V; Seno N; Kakkar VV
    Biochem J; 1988 Sep; 254(2):547-51. PubMed ID: 2902851
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antifactor Xa activity and antithrombotic activity in rats of structural analogues of the minimum antithrombin III binding sequence: discovery of compounds with a longer duration of action than of the natural pentasaccharide.
    Meuleman DG; Hobbelen PM; Van Dinther TG; Vogel GM; Van Boeckel CA; Moelker HC
    Semin Thromb Hemost; 1991; 17 Suppl 1():112-7. PubMed ID: 2068564
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biochemical and pharmacological properties of SANORG 32701. Comparison with the "synthetic pentasaccharide' (SR 90107/ORG 31540) and standard heparin.
    Herbert JM; Hérault JP; Bernat A; van Amsterdam RG; Vogel GM; Lormeau JC; Petitou M; Meuleman DG
    Circ Res; 1996 Sep; 79(3):590-600. PubMed ID: 8781492
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anticoagulant and antithrombin effects of intimatan, a heparin cofactor II agonist.
    Buchanan MR; Brister SJ
    Thromb Res; 2000 Sep; 99(6):603-12. PubMed ID: 10974347
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unfractionated heparin inhibits thrombin-catalysed amplification reactions of coagulation more efficiently than those catalysed by factor Xa.
    Ofosu FA; Hirsh J; Esmon CT; Modi GJ; Smith LM; Anvari N; Buchanan MR; Fenton JW; Blajchman MA
    Biochem J; 1989 Jan; 257(1):143-50. PubMed ID: 2920007
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heparin, carboxyl-reduced sulfated heparin, and Trestatin A sulfate. Antiproliferative and anticoagulant activities.
    Wessel HP; Hosang M; Tschopp TB; Weimann BJ
    Carbohydr Res; 1990 Sep; 204():131-9. PubMed ID: 2279243
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis of heparin-like antithrombotics having perphosphorylated thrombin binding domains.
    Buijsman RC; Basten JE; Dreef-Tromp CM; van der Marel GA; van Boeckel CA; van Boom JH
    Bioorg Med Chem; 1999 Sep; 7(9):1881-90. PubMed ID: 10530936
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reactivity of a hereditary abnormal antithrombin III fraction in the inhibition of thrombin and factor Xa.
    Tran TH; Bondeli C; Marbet GA; Duckert F
    Thromb Haemost; 1980 Oct; 44(2):92-5. PubMed ID: 7455997
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The Choay domain -- the structure responsible for the anticoagulant action of heparins].
    Hemker HC; al Dieri R; Wagenvoord R; Béguin S
    Bull Acad Natl Med; 2003; 187(1):59-66; discussion 66-7. PubMed ID: 14556454
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Isolation of a pure octadecasaccharide with antithrombin activity from an ultra-low-molecular-weight heparin.
    Mourier PA; Guichard OY; Herman F; Viskov C
    Anal Biochem; 2014 May; 453():7-15. PubMed ID: 24561026
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The region of antithrombin interacting with full-length heparin chains outside the high-affinity pentasaccharide sequence extends to Lys136 but not to Lys139.
    Arocas V; Turk B; Bock SC; Olson ST; Björk I
    Biochemistry; 2000 Jul; 39(29):8512-8. PubMed ID: 10913257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.